Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 6 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $212.53 (18.02% upside)

Analysts' Ratings History for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/27/2015OppenheimerReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
4/26/2015Brean CapitalReiterated RatingBuy$215.00ViewTweet This Rating  Share This Rating on StockTwits
4/26/2015Piper JaffrayReiterated RatingOverweight$214.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2015NomuraLower Price TargetNeutral$223.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
4/24/2015Jefferies GroupBoost Price TargetHold$164.00 -> $167.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2015BTIG ResearchReiterated RatingBuy$250.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2015ZacksDowngradeOutperform -> Neutral$195.00ViewTweet This Rating  Share This Rating on StockTwits
2/6/2015ZacksUpgradeNeutral -> Outperform$214.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Citigroup Inc.Reiterated RatingHold$199.00 -> $208.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Jefferies GroupBoost Price TargetHold$161.00 -> $164.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Leerink SwannBoost Price TargetOutperform$200.00 -> $224.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2015Stifel NicolausBoost Price TargetBuy$230.00 -> $236.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Brean CapitalReiterated RatingBuy$215.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Piper JaffrayReiterated RatingOverweight$214.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Jefferies GroupLower Price TargetHold$170.00 -> $161.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2015BarclaysInitiated CoverageOverweight$225.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015BTIG ResearchInitiated CoverageBuy$250.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015Morgan StanleyDowngradeOverweight -> Equal Weight$202.00ViewTweet This Rating  Share This Rating on StockTwits
1/5/2015NomuraDowngradeBuy -> Neutral$224.00 -> $223.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2014ZacksReiterated RatingNeutral -> Neutral$198.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014JPMorgan Chase & Co.Reiterated RatingOverweight$220.00 -> $225.00ViewTweet This Rating  Share This Rating on StockTwits
10/27/2014ZacksReiterated RatingNeutral -> Neutral$200.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2014Bank of AmericaInitiated CoverageBuy$197.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014ZacksReiterated RatingNeutral -> Neutral$168.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014SunTrustInitiated CoverageBuy$229.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Credit Suisse Group AGInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
7/25/2014NomuraReiterated RatingBuy$222.00 -> $224.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014Stifel NicolausReiterated RatingBuy$220.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014JPMorgan Chase & Co.Reiterated RatingOverweight$210.00 -> $220.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014Credit Suisse Group AGReiterated RatingNeutral$174.00 -> $179.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014ZacksReiterated RatingNeutral -> Neutral$176.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014JPMorgan Chase & Co.Reiterated RatingOverweight$200.00 -> $210.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Stifel NicolausReiterated RatingBuy$219.00 -> $220.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/27/2014Credit Suisse Group AGBoost Price TargetNeutral$171.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Brean CapitalBoost Price Target$200.00 -> $215.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014NomuraBoost Price Target$214.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Stifel NicolausBoost Price TargetBuy$207.00 -> $219.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014BarclaysBoost Price TargetOutperform$181.00 -> $193.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Jefferies GroupBoost Price TargetHold$106.00 -> $145.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Leerink SwannBoost Price Target$125.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014BarclaysBoost Price TargetOverweight$141.00 -> $181.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Stifel NicolausBoost Price TargetBuy$138.00 -> $207.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2014Brean CapitalBoost Price TargetBuy$142.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysReiterated RatingOverweight$127.00 -> $141.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014NomuraInitiated CoverageBuy$150.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Canaccord GenuityBoost Price TargetBuy$138.00 -> $161.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Goldman SachsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$172.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013OppenheimerBoost Price Target$115.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Jefferies GroupBoost Price TargetHold$97.00 -> $106.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Canaccord GenuityBoost Price TargetBuy$132.00 -> $138.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013BarclaysBoost Price TargetOverweight$121.00 -> $127.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Stifel NicolausBoost Price TargetBuy$131.00 -> $138.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price TargetHold$122.00 -> $139.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Jefferies GroupBoost Price TargetHold$88.00 -> $97.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013BarclaysBoost Price TargetOverweight$118.00 -> $121.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013Brean CapitalReiterated RatingBuy$120.00ViewTweet This Rating  Share This Rating on StockTwits
5/31/2013Credit Suisse Group AGInitiated CoverageNeutral$110.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/27/2013 forward)